Who is the CEO of Global X China Biotech ETF?

Key leadership information for Global X China Biotech ETF, including the current CEO, is detailed in the company's official annual reports and proxy statements.

What industry does Global X China Biotech ETF belong to?

Global X China Biotech ETF operates in the Asset Management - Global industry within the Financial Services sector.

Where is Global X China Biotech ETF headquartered?

Global X China Biotech ETF is headquartered at HK.

What is the IPO date of Global X China Biotech ETF?

Global X China Biotech ETF went public on July 25, 2019.

How many employees does Global X China Biotech ETF have?

The total number of employees at Global X China Biotech ETF is disclosed periodically in the company's annual financial reports.

Global X China Biotech ETF

2820.HK•HKSE

Financial Services

Asset Management - Global

HK$72.90

HK$-1.70(-2.28%)

Global X China Biotech ETF (2820.HK) Company Profile & Overview

Explore Global X China Biotech ETF’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Global X China Biotech ETF (2820.HK) Company Profile & Overview

The Global X China Biotech ETF seeks to provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the Underlying Index.

SectorFinancial Services

IndustryAsset Management - Global

Company Facts

IPO DateJul 25, 2019

CountryHK

Actively Trading

Frequently Asked Questions

;